Navigation Links
THE PLANNING SHOP international Announces Oncology Business Unit
Date:6/30/2010

PHILADELPHIA and LONDON, June 30 /PRNewswire/ -- THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area. This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.

Oncology is a complex, fast moving therapeutic area.  Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer.  Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products.  The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands. Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.

"TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit," said Kim Hughes, Managing Director, TPSi London.  "Her joining TPSi represents the merger of deep oncol
'/>"/>

SOURCE THE PLANNING SHOP international
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
3. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. Centage Corporation Announces Planning Maestro Business Performance Management Software for Mid-Market Enterprises
6. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
7. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
8. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
9. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ... remaining soft. , This solid economic news is having a ...
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... 22, 2014 GenomeDx Biosciences today announced that ... Classifier, a genomic test for prostate cancer, was able ... managed by radical prostatectomy without adjuvant therapy. Although rapid ... uncommon, using tumor genomics to identify these men who ... an important advance. The study has been published ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... Finesse Solutions, LLC, a,manufacturer of measurement and control ... its new sales and service center in,Northborough, MA, in ... Solutions is converting its Irvine, CA facility to a,service ... also plans on,opening a European sales and service center ...
... MITI ), a biopharmaceutical company developing novel, ... autoimmune,diseases, today announced that it will host a ... 2008, at 9:00 am Eastern Time (2:00 pm,Central ... full year 2007,financial results. Micromet anticipates releasing its ...
... PharmAthene, Inc., a,biodefense company specializing in the ... biological threats, announced,today that it has completed the ... spectrum chemical nerve agent prophylaxis., The PK ... used the final,pegylated version of rBChE for the ...
Cached Biology Technology:Finesse Solutions Expands by Opening Sales and Service Centers 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 4
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Leaders within the U.S. biomedical device industry unveiled today ... enhance the development of devices with great clinical utility, ... become a key component of the nation,s drive to ... access to device innovation that improves human health, the ...
... OF PRUSSIA, Pa., June 16, 2011 Omnicare Clinical Research, ... re-branding of the company under the name Theorem Clinical Research. ... separation from its former parent company in a deal that ... private equity firm based in Providence, R.I., acquired the CRO ...
... eruption in early June, several NASA satellites have captured images ... Volcano called Puyehue-Cordn Caulle and have tracked it around the ... image gallery that shows the progression of the plume around ... includes the Puyehue volcano, the Cordn Caulle rift zone and ...
Cached Biology News:U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 2U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 3U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 4Omnicare Clinical Research Re-Brands as Theorem Clinical Research 2Omnicare Clinical Research Re-Brands as Theorem Clinical Research 3NASA satellite gallery shows Chilean volcano plume moving around the world 2NASA satellite gallery shows Chilean volcano plume moving around the world 3
... internal standard for the quantification of 5-OxoETE ... is a polyunsaturated keto acid formed by ... It stimulates cytosolic calcium levels in neutrophils ... selectively stimulates the migration and degranulation of ...
... 4,600 to Over 3 Million Genotypes Per ... capable of performing 4,600 to over 3 ... GenomeLab family of products*, this automated, scalable, ... SNPs in each well of an arrayed ...
... These protein size markers are a mixture ... 16 to 100 kDa. The markers provide ... gels after staining with Coomassie blue. Because ... II sequence, the markers can also be ...
... solid. A nucleoside antibiotic that inhibits ... of N-glycosidic protein-carbohydrate linkages. Active ... yeasts, fungi, and viruses. Inhibits the ... human T-lymphoblastoid cells. Also inhibits thrombin-induced ...
Biology Products: